BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2178879)

  • 1. Modification of hyperactive xenograft rejection by ex vivo xenoantibody adsorption.
    Han LK; Henry ML; Orosz CG; Sedmak DD; Ferguson RM
    Curr Surg; 1990; 47(1):15-7. PubMed ID: 2178879
    [No Abstract]   [Full Text] [Related]  

  • 2. Modification of xenograft hyperacute rejection via xenoantibody depletion.
    Henry ML; Han LK; Orosz CG; Sedmak D; Ferguson RM
    Transplant Proc; 1990 Jun; 22(3):1081-2. PubMed ID: 2349665
    [No Abstract]   [Full Text] [Related]  

  • 3. Deposition of polyreactive antibodies in xenograft rejection: detection using antiidiotype monoclonal antibodies.
    Geller RL; Turman M; Bach FH; Platt JL
    Transplant Proc; 1992 Apr; 24(2):595. PubMed ID: 1566444
    [No Abstract]   [Full Text] [Related]  

  • 4. Xenoperfusion of pig kidney with human AB or O whole blood.
    Otte KE; Andersen N; Jørgensen KA; Kristensen T; Barfort P; Starklint H; Larsen S; Kemp E
    Transplant Proc; 1990 Jun; 22(3):1091-2. PubMed ID: 2349669
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of xenoantibody and formed cellular blood elements on ex vivo xenograft hyperacute rejection.
    Han LK; Henry ML; Ferguson RM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):574-5. PubMed ID: 1990612
    [No Abstract]   [Full Text] [Related]  

  • 6. Role of naturally occurring xenoantibodies in hyperacute rejection strengthened by their avid binding to ex vivo pig to human liver xenografts and to isolated pig liver preparations.
    Nair J; Fair JH; Burdick JF; Stephenson GR; Klein AS; Olson JL; Maley WR; Kittur DS
    Transplant Proc; 1994 Jun; 26(3):1344-5. PubMed ID: 8029934
    [No Abstract]   [Full Text] [Related]  

  • 7. Prolongation of cardiac xenograft survival by double filtration plasmapheresis and ex vivo xenoantibody adsorption.
    Kimikawa M; Agishi T; Teraoka S; Suga H; Hayasaka Y; Ota K
    Transplant Proc; 1992 Apr; 24(2):447. PubMed ID: 1566383
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo and in vitro study of hyperacute rejection mechanism of renal discordant xenograft.
    Marino IR; Ferla G; Celli S; Stieber A; Muttillo I; Maggiano N; Perrelli L; Musiani P
    Transplant Proc; 1991 Feb; 23(1 Pt 1):620-2. PubMed ID: 1990627
    [No Abstract]   [Full Text] [Related]  

  • 9. Antibody depletion prolongs xenograft survival.
    Henry ML; Han LK; Davies EA; Sedmak DD; Ferguson RM
    Surgery; 1994 Mar; 115(3):355-61. PubMed ID: 8128359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of leflunomide to reduce xenoantibody titers in vivo: an evaluation of the prolongation of discordant xenograft survival.
    Lucien J; Marath A; Rayat G; Thliveris J; Koshal A; Yatscoff R
    Transplant Proc; 1996 Apr; 28(2):704-7. PubMed ID: 8623356
    [No Abstract]   [Full Text] [Related]  

  • 11. The renal xenograft rejection. Effect of hyperimmune F(ab') 2 and succinylated IgG.
    Habal MB; Misra MK; Busch GJ; Carpenter CB; Birtch AG
    Transplantation; 1972 Dec; 14(6):796-8. PubMed ID: 4566275
    [No Abstract]   [Full Text] [Related]  

  • 12. Human xenoreactive natural antibodies--avidity and targets on porcine endothelial cells.
    Vanhove B; Bach FH
    Transplantation; 1993 Nov; 56(5):1251-3. PubMed ID: 8249132
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunochemical characterization of the binding of human immunoglobulins to pig vascular endothelium.
    Tuso PJ; Cramer DV; Yasunaga C; Cosenza C; Makowka L
    Transplant Proc; 1992 Apr; 24(2):596-7. PubMed ID: 1566445
    [No Abstract]   [Full Text] [Related]  

  • 14. Newborn discordant cardiac xenotransplantation in primates: a model of natural antibody depletion.
    Michler RE; Xu H; O'Hair DP; Shah A; Kwiatkowski PA; Minanov O; Itescu S
    Transplant Proc; 1996 Apr; 28(2):651-2. PubMed ID: 8623325
    [No Abstract]   [Full Text] [Related]  

  • 15. Abrogation of baboon natural xenoantibody to pig splenocytes by DL-penicillamine.
    Xu H; Kwiatkowski P; Chen JM; Kaplon RJ; Edwards NM; Dong X; Berger C; Michler RE
    Transplantation; 1994 Dec; 58(12):1299-303. PubMed ID: 7809920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on "Ontogeny of antipig xenoantibody and hyperacute rejection".
    Cairns T
    Transplantation; 2000 Aug; 70(4):568-9. PubMed ID: 10972210
    [No Abstract]   [Full Text] [Related]  

  • 17. Hyperacute rejection of renal discordant xenograft (pig-to-rabbit): model assessment and rejection mechanisms.
    Marino IR; Ferla G; Celli S; Stieber A; Muttillo I; Maggiano N; Mazzaferro V; Perrelli L; Musiani P
    Transplant Proc; 1990 Jun; 22(3):1071-6. PubMed ID: 2190372
    [No Abstract]   [Full Text] [Related]  

  • 18. Specificity of the heteroantibody in xenograft rejection.
    Mozes MF; Shons AR; Harris NS; Merino GE; Moberg AW; Campos RA; Najarian JS
    Surg Forum; 1971; 22():244-6. PubMed ID: 4941308
    [No Abstract]   [Full Text] [Related]  

  • 19. Significance of anti-Gal IgG in chronic xenograft rejection.
    Galili U
    Transplant Proc; 1999; 31(1-2):940-1. PubMed ID: 10083416
    [No Abstract]   [Full Text] [Related]  

  • 20. Detection of targets of human preformed natural antibodies.
    Citterio F; Maggiano N; Tartaglione R; Foco M; Gattavilla N; Pozzetto U; Marinelli R; Azzaretto M; Castagneto M
    Transplant Proc; 1992 Apr; 24(2):437-8. PubMed ID: 1566378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.